CRISPR Therapeutics AG (NASDAQ:CRSP)

63.87
Delayed Data
As of Jul 01
 +3.10 / +5.10%
Today’s Change
42.51
Today|||52-Week Range
163.00
-15.72%
Year-to-Date

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 112.00, with a high estimate of 220.00 and a low estimate of 46.00. The median estimate represents a +75.36% increase from the last price of 63.87.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.22
Sales
$2.2M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.50%
 
 
 
 
 
 
Growthannually -290.65%
 
 
 
 
 
 

Sales

Growthquarterly 135.37%
 
 
 
 
 
 
Growthannually -94.46%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.